A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
for Pediatric
Drug: Aficamten
Sites in Morristown +24 more locations
Sponsor: Cytokinetics
Sex: All·Age: 12 - 17
Code: NCT06412666·Phase 2, Phase 3·Recruiting·Listed May 2024